| Natural history of clinical manifestations in activated phosphoinositide 3-kinase δ syndrome (APDS): Time-to-event analyses using the European Society for Immunodeficiencies-APDS registry | Clinical immunology |  | | 2026 | 3 | 4 |
|
| Vaccine Immunity Against Pneumococcus in Children With Sickle Cell Disease : A Retrospective Single-center Study | The Pediatric infectious disease journal | | | 2026 | 8 | 35 |
|
| Five Years of Combined Newborn Screening Quantifying TREC and KREC in Switzerland | Journal of allergy and clinical immunology. In practice | | | 2026 | 1 | 4 |
|
| Machine learning-assisted diagnosis classification of primary immune dysregulation using IDDA2.1 phenotype profiling | The journal of allergy and clinical immunology | | | 2026 | 2 | 4 |
|
| Epidemiology and management of malignancies in patients with inborn errors of immunity-An ESID registry study of 19,959 patients | The journal of allergy and clinical immunology | | | 2026 | 1 | 3 |
|
| Natural History of Swiss Infants with Non-SCID T-cell Lymphopenia Detected by Newborn Screening : A Cohort Study | Journal of clinical immunology | | | 2025 | 1 | 1 |
|
| Maladies auto-immunes du système nerveux central chez l’enfant : Efficacité ou immaturité immunitaire | Revue médicale suisse | | | 2025 | 2 | 1 |
|
| Reply to Hinpetch Daungsupawong | Pediatric allergy and immunology |  | | 2025 | 32 | 0 |
|
| Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) functional deficiency caused by biallelic LRBA missense variants characterized by Evans syndrome or colitis | The journal of allergy and clinical immunology | | | 2025 | 1 | 0 |
|
| Well-Being of Children and Adolescents with and without Special Health Care Needs Following the Lifting of Pandemic-Related Restrictions | The journal of pediatrics | | | 2025 | 1 | 0 |
|
| The interplay of social and family environments in shaping adolescent health behaviours : a population-based study | Public health | | | 2025 | 4 | 0 |
|
| Cow's milk protein allergy with protein-losing enteropathy under the scope | JPGN reports | | | 2025 | 16 | 76 |
|
| Inborn errors of immunity: Manifestation, treatment, and outcome-an ESID registry 1994-2024 report on 30,628 patients | Journal of human immunity | | | 2025 | 1 | 1 |
|
| ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma | The journal of experimental medicine | | | 2025 | 1 | 0 |
|
| Vaccine immunity in patients with 22q11.2 microdeletion syndrome | Pediatric allergy and immunology | | | 2025 | 96 | 338 |
|
| Quoi de neuf dans les maladies rhumatologiques pédiatriques ? | Revue médicale suisse | | | 2025 | 3 | 1 |
|
| Cardiac assessment and inflammatory markers in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2 (PIMS-TS) treated with methylprednisolone versus intravenous immunoglobulins : 6-month follow-up outcomes of the randomised controlled Swissped RECOVERY trial | EClinicalMedicine | | | 2024 | 82 | 80 |
|
| Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children : The potential role of prior natural infection | Pediatric allergy and immunology | | | 2024 | 135 | 530 |
|
| Vaccine immunity in children after hematologic cancer treatment : a retrospective single-center study | Journal of pediatric hematology/oncology | | | 2024 | 70 | 209 |
|
| One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19 | The Pediatric infectious disease journal | | | 2024 | 79 | 153 |
|
| Swissped-RECOVERY : masked independent adjudication for the interpretation of non-randomised treatment in a two-arm open-label randomised controlled trial (methylprednisolone vs immunoglobulins) in Paediatric Inflammatory Multisystem Syndrome Temporally Associated with SARS-CoV-2 (PIMS-TS) involving 10 secondary and tertiary paediatric hospitals in Switzerland | BMJ open | | | 2024 | 10 | 331 |
|
| Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection | Human Genetics and Genomics advances | | | 2024 | 18 | 58 |
|
| Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases | The Journal of experimental medicine | | | 2024 | 13 | 43 |
|
| COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Children | The Pediatric infectious disease journal | | | 2024 | 13 | 58 |
|
| Assessing vaccine-induced immunity against pneumococcus, hepatitis A and B over a 9-year follow-up in pediatric liver transplant recipients : A nationwide retrospective study | American journal of transplantation | | | 2024 | 109 | 135 |
|
| Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children | Science | | | 2023 | 96 | 68 |
|
| Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonates | Clinical infectious diseases | | | 2023 | 94 | 200 |
|
| Utilité clinique des genome boards pour les maladies génétiques complexes | Revue médicale suisse | | | 2023 | 198 | 202 |
|
| Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 | Frontiers in immunology | | | 2023 | 206 | 62 |
|
| Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease | The Journal of experimental medicine | | | 2023 | 62 | 33 |
|
| Methylprednisolone versus intravenous immunoglobulins in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) : an open-label, multicentre, randomised trial | The Lancet. Child & adolescent health | | | 2023 | 64 | 133 |
|
| Hyper-IgE syndrome presenting with early life craniosynostosis in monozygotic twin sisters | Pediatric allergy and immunology | | | 2023 | 116 | 145 |
|
| Autoantibodies to a nodal isoform of neurofascin in pediatric chronic inflammatory demyelinating polyneuropathy | Child neurology open | | | 2023 | 39 | 197 |
|
| Quelles pathologies immunologiques sont ciblées par la médecine de précision ? | Revue médicale suisse | | | 2023 | 53 | 69 |
|
| Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 | Genome medicine | | | 2023 | 83 | 152 |
|
| Vaccination of immunosuppressed children in clinical practice | | | | 2022 | 69 | 0 |
|
| Endothelial glycocalyx degradation in multisystem inflammatory syndrome in children related to COVID-19 | Journal of molecular medicine | | | 2022 | 87 | 161 |
|
| Acceptability of COVID-19 Vaccine Among Hospital Employees in the Department of Paediatrics, Gynaecology and Obstetrics in the University Hospitals of Geneva, Switzerland | Frontiers in public health | | | 2022 | 125 | 123 |
|
| Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms | Frontiers in immunology | | | 2022 | 308 | 197 |
|
| Novel approaches to reactivate pertussis immunity | Expert review of vaccines | | | 2022 | 173 | 867 |
|
| Evaluation of rotavirus vaccine administration among a 22q11.2DS patient population | Allergy, asthma, and clinical immunology | | | 2022 | 148 | 157 |
|
| Multicenter Randomized Trial of Methylprednisolone vs. Intravenous Immunoglobulins to Treat the Pediatric Inflammatory Multisystem Syndrome — Temporally Associated With SARS-CoV-2 (PIMS-TS): Protocol of the Swissped RECOVERY Trial | Frontiers in pediatrics | | | 2022 | 227 | 144 |
|
| Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | | | 2022 | 203 | 216 |
|
| Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide | Frontiers in immunology | | | 2021 | 294 | 296 |
|
| Maladies infectieuses | Revue médicale suisse | | | 2021 | 395 | 124 |
|
| Best Practice Recommendations for the Diagnosis and Management of Children With Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2 (PIMS-TS; Multisystem Inflammatory Syndrome in Children, MIS-C) in Switzerland | Frontiers in pediatrics | | | 2021 | 91 | 311 |
|
| Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | | | 2021 | 443 | 328 |
|
| Meningitis Caused by the Live Varicella Vaccine Virus: Metagenomic Next Generation Sequencing, Immunology Exome Sequencing and Cytokine Multiplex Profiling | Viruses | | | 2021 | 230 | 310 |
|
| Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | | | 2021 | 323 | 241 |
|
| X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children - A Case Report | Frontiers in pediatrics | | | 2021 | 108 | 124 |
|
| Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19 | Journal of the Pediatric Infectious Diseases Society | | | 2021 | 337 | 247 |
|
| Case report: case series of children with multisystem inflammatory syndrome following SARS-CoV-2 infection in Switzerland | Frontiers in pediatrics | | | 2021 | 198 | 193 |
|
| Pediatric Acute B-Cell Lymphoblastic Leukemia Developing Following Recent SARS-CoV-2 Infection | Journal of pediatric hematology/oncology | | | 2021 | 279 | 0 |
|
| Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT | Frontiers in immunology | | | 2021 | 282 | 891 |
|
| Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipients | Vaccine | | | 2021 | 232 | 3 |
|
| Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention | Vaccines | | | 2021 | 244 | 897 |
|
| Vaccination in immunosuppressed children: a comprehensive review and practical guide | | | | 2020 | 450 | 4 |
|
| Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial | Clinical Microbiology and Infection | | | 2020 | 337 | 259 |
|
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19) | Clinical Infectious Diseases | | | 2020 | 507 | 400 |
|
| Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | | | 2020 | 526 | 238 |
|
| Optimal timing of influenza vaccine during pregnancy: A systematic review and meta-analysis | Influenza and other Respiratory Viruses | | | 2019 | 281 | 281 |
|
| Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidates | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | | | 2019 | 454 | 3 |
|
| Germline CBM-opathies: From immunodeficiency to atopy | Journal of Allergy and Clinical Immunology | | | 2019 | 258 | 0 |
|
| Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial | Clinical Infectious Diseases | | | 2019 | 329 | 381 |
|
| A 19-month-old boy with refractory cervical adenitis | Pediatric Infectious Disease Journal | | | 2019 | 386 | 1 |
|
| Activated Phosphoinositide 3 Kinase Delta Syndrome (APDS): A Primary Immunodeficiency Mimicking Lymphoma | Journal of Pediatric Hematology / Oncology | | | 2018 | 507 | 1 |
|
| Review of maternal immunisation during pregnancy: focus on pertussis and influenza | Swiss Medical Weekly | | | 2017 | 355 | 275 |
|
| Parler vaccination aux parents : un défi pour le médecin de premier recours | Revue médicale suisse | | | 2017 | 367 | 155 |
|
| Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal Immunization | Clinical Infectious Diseases | | | 2017 | 629 | 373 |
|
| Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis | Clinical infectious diseases | | | 2016 | 756 | 5 |
|
| Impact de la vaccination sur les otites moyennes aiguës | Revue médicale suisse | | | 2016 | 434 | 1 |
|
| Awareness of Cytomegalovirus Infection among Pregnant Women in Geneva, Switzerland: A Cross-sectional Study | International journal of environmental research and public health | | | 2015 | 702 | 406 |
|
| Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom | Clinical and vaccine immunology | | | 2014 | 573 | 0 |
|
| Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom | Pediatric Infectious Disease Journal | | | 2013 | 174 | 0 |
|
| The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age | Vaccine | | | 2013 | 449 | 338 |
|
| Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn | The Pediatric infectious disease journal | | | 2013 | 732 | 3 |
|
| Acceptability of maternal immunization against influenza: the critical role of obstetricians | Journal of maternal-fetal & neonatal medicine | | | 2012 | 753 | 0 |
|
| Vaccination against seasonal flu in Switzerland: The indecision of pregnant women encouraged by healthcare professionals | Revue d'épidémiologie et de santé publique | | | 2012 | 732 | 3 |
|
| Baseline polysaccharide-specific antibodies may not consistently inhibit booster antibody responses in infants to a serogroup C meningococcal protein-polysaccharide conjugate vaccine | Vaccine | | | 2012 | 224 | 290 |
|
| Vaccination during pregnancy to protect infants against influenza: why and why not? | Vaccine | | | 2011 | 618 | 0 |
|
| Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy | Expert Review of Vaccines | | | 2011 | 184 | 0 |
|
| Comparison of a limiting dilution assay and ELISpot for detection of memory B-cells before and after immunisation with a protein-polysaccharide conjugate vaccine in children | Journal of Immunological Methods | | | 2010 | 182 | 0 |
|
| Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine | Immunology | | | 2009 | 179 | 326 |
|
| Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans | Blood | | | 2009 | 237 | 306 |
|
| The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response | The Journal of immunology | | | 2008 | 606 | 2 |
|
| Sustaining immunity after immunization against encapsulated bacteria | Human Vaccines | | | 2008 | 191 | 0 |
|
| Persistence of protection against invasive bacteria-memory b cell response in infants after immunisation | | | | 2008 | 455 | 1 |
|
| Une étude de la réponse des cellules B mémoires au vaccin polysaccharidique conjugué contre le méningocoque du sérogroupe C | | | | 2006 | 1,183 | 670 |
|
